Gibson Neil W

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -58% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gibson Neil W's trades of TCR2 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
157.31
Quantity 37,729 +21.7%
Value US$4,396,254
Transaction date
Sale
Price
322.92
Quantity 27,336 +11.5%
Value US$2,155,432
Transaction date
Sale
Price
104.73
Quantity 16,781 +10.4%
Value US$4,871,101
Transaction date
Sale
Price
6.49
Quantity 3,009 -30.3%
Value US$19,528
Transaction date
Sale
Price
6.60
Quantity 17,723 -64.1%
Value US$117,043
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-03-27 2020-03-20
S Sale
37,729 +21.7%
157.31
US$4,396,254 		37,729 +21.7% 157.31 US$4,396,254
2020-03-27 2020-03-19
S Sale
27,336 +11.5%
322.92
US$2,155,432 		27,336 +11.5% 322.92 US$2,155,432
2020-03-27 2020-03-18
S Sale
16,781 +10.4%
104.73
US$4,871,101 		16,781 +10.4% 104.73 US$4,871,101
2020-03-27 2020-03-17
S Sale
3,009 -30.3%
6.49
US$19,528 		3,009 -30.3% 6.49 US$19,528
2020-03-27 2020-03-16
S Sale
17,723 -64.1%
6.60
US$117,043 		17,723 -64.1% 6.60 US$117,043
2020-03-27 2020-03-13
S Sale
52,000 -65.3%
6.52
US$338,894 		52,000 -65.3% 6.52 US$338,894